Over 2.8 million Americans get antibiotic-resistant bacterial infections annually, and about 35,000 of those patients do not make it through their infection, according to the Centers for Disease Control and Prevention.
Hongjun (Henry) Liang, Ph.D., of the Texas Tech University Health Sciences Center (TTUHSC) Department of Cell Physiology and Molecular Biophysics, has largely focused his research on creating novel nanoparticles known as nanoantibiotics that address bacterial infections, particularly those that are resistant to treatment with commonly used antibiotics, to find solutions to the problem of antibiotic resistance.
As of July 26th, 2022, a US patent titled “Hydrophilic Nanostructured Membrane Active Antimicrobials With High Activity, Selectivity And Biodegradability” had been issued in connection with Liang’s work, enabling the Liang laboratory team to manufacture the innovative nanoantibiotics.
We have a lot of antibiotics already being used in the clinics, and many of them are quite effective to ordinary infections. But we are facing this increasing challenge with MRSA (methicillin-resistant staphylococcus aureus) and other kinds of drug-resistant bacteria, which are the bacteria that turns ordinary infections into life-threatening events.
Hongjun Liang, Department of Cell Physiology and Molecular Biophysics, Texas Tech University Health Sciences Center
The ability of a molecule to repel water (hydrophobicity) or to attract water and dissolve in it (hydrophilicity) has been shown to have a major impact on cells in previous studies. According to Liang, a material will have a higher negative effect the more hydrophobic it is.
He emphasized that there is, however, no quantitative benchmark for the acceptable level of hydrophobicity.
Liang added, “Basically, you can kill bacteria when you increase hydrophobicity. But it also will kill healthy cells, and we don’t want that.”
The Liang team created unique hydrophilic nanoantibiotics in a study published in January 2022 in Nature Communications. These nanoantibiotics had the appearance of tiny hairy spheres and were made of many hydrophilic polymer brushes grafted onto silica nanoparticles of various sizes.
These man-made substances, which are also produced by Liang’s lab, are intended to kill bacteria by disrupting their membranes by utilizing a distinct method of membrane remodeling that affects bacterial membranes while leaving mammalian cells unharmed.
This was the third paper on nanoantibiotics that the Liang lab has published. The first and second publications that described the hydrophilic nanoantibiotic design approach were released in 2017 by ACS Infectious Disease and in 2020 by Biomacromolecules.
Both were highlighted by Chemical & Engineering News and featured as cover stories in their respective journals.
Liang said his team is now concentrating on a two-pronged approach to enhance and improve the nanoantibiotics for use in patients, armed with the three published findings and the patent.
Pushing for clinical trials is the first strategy, which Liang defined as the research and academic component of his approach. The Liang lab will begin that procedure by submitting new applications for federal funding that support animal studies and ultimately result in clinical trials on human subjects.
He stated, “That is more like the research and academic side of our effort.”
Working with the Texas Tech University Innovation Hub to assist in the commercialization of Liang’s lab’s invention is the second element of his approach.
“By taking the training opportunity on research commercialization from our Innovation Hub, hopefully, we are able to identify interested parties in the pharmaceutical industry who are able or willing to collaborate with us. One of our likely directions is to apply for an SBIR (Small Business Innovation Research) grant to pilot scale production. That’s our two-pronged approach,” stated Liang.
Infection is a major concern for both scientists and practicing physicians, according to Liang. By harnessing innovation to develop a new generation of antibiotics, he hopes to be able to overcome this issue.
Liang concluded, “That is our goal and we are well on our way to that. I can’t say this is the only way forward; of course, there are many different ways. The novelty of our contribution is to tackle this challenge by designing antibiotics from a nanoengineering point of view. This is a very new path that is not well explored, and we are proud of our progress so far.”
News
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
Aging Cells May Be Hiding From the Immune System – Scientists Think They Know How
Your immune system is supposed to clear out damaged cells. Researchers may have found how some of them hide and linger as the body ages. Researchers led by Cedars-Sinai Health Sciences University have identified [...]
Your Voice May Reveal How Fast Your Brain Is Aging
Researchers have developed a machine-learning “speech clock” that estimates age from subtle patterns in how people speak and what they say. It is possible that people’s voices may contain certain signals of aging that [...]
Optogenetics Pioneers Win 2026 Nobel Prize in Physiology or Medicine
The 2026 Nobel Prize in Physiology or Medicine has been awarded to Peter Hegemann, Georg Nagel, and Karl Deisseroth for the development of optogenetics, a revolutionary technology that uses light to control individual neurons [...]
Molecular Manufacturing: The Future of Nanomedicine – From NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
What is ‘American Covid’ and how bad is it?
Cases of so-called ‘American Covid’ are on the rise in the UK. The strain is officially called XFG, or ‘Stratus’, and is the most common variant in North America, hence the name. It might soon [...]
